Search Results - Marika Alborghetti

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson’s disease by Marika Alborghetti, Alessia Ceccherelli, Matteo Caridi, Ferdinando Nicoletti, Giuseppe Battaglia, Valeria Bruno

    Published in npj Parkinson's Disease (2025-10-01)
    Get full text
    Article


  2. 2

    Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR by Sabrina Staffieri, Veronica Russo, Maria Antonietta Oliva, Marika Alborghetti, Miriam Russo, Antonietta Arcella

    Published in Molecules (2023-08-01)
    Get full text
    Article


  3. 3

    Step-Counting Accuracy of a Commercial Smartwatch in Mild-to-Moderate PD Patients and Effect of Spatiotemporal Gait Parameters, Laterality of Symptoms, Pharmacological State, and C... by Edoardo Bianchini, Bianca Caliò, Marika Alborghetti, Domiziana Rinaldi, Clint Hansen, Nicolas Vuillerme, Walter Maetzler, Francesco E. Pontieri

    Published in Sensors (2022-12-01)
    Get full text
    Article


  4. 4

    The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson’s Disease by Edoardo Bianchini, Domiziana Rinaldi, Marika Alborghetti, Marta Simonelli, Flavia D’Audino, Camilla Onelli, Elena Pegolo, Francesco E. Pontieri

    Published in Brain Sciences (2024-01-01)
    Get full text
    Article


  5. 5

    Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study by Lanfranco De Carolis, Silvia Galli, Edoardo Bianchini, Domiziana Rinaldi, Manikandan Raju, Bianca Caliò, Marika Alborghetti, Francesco E. Pontieri

    Published in Brain Sciences (2023-01-01)
    Get full text
    Article


  6. 6

    Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch by Edoardo Bianchini, Silvia Galli, Marika Alborghetti, Lanfranco De Carolis, Alessandro Zampogna, Clint Hansen, Nicolas Vuillerme, Antonio Suppa, Francesco E. Pontieri

    Published in Sensors (2023-11-01)
    Get full text
    Article


  7. 7

    Minimal Clinically Important Difference of Average Daily Steps Measured Through a Consumer Smartwatch in People With Mild-to-Moderate Parkinson Disease: Cross-Sectional Study by Edoardo Bianchini, Marika Alborghetti, Silvia Galli, Clint Hansen, Alessandro Zampogna, Antonio Suppa, Marco Salvetti, Francesco Ernesto Pontieri, Domiziana Rinaldi, Nicolas Vuillerme

    Published in JMIR mHealth and uHealth (2025-07-01)
    Get full text
    Article


  8. 8

    Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional Study by Edoardo Bianchini, Domiziana Rinaldi, Lanfranco De Carolis, Silvia Galli, Marika Alborghetti, Clint Hansen, Antonio Suppa, Marco Salvetti, Francesco Ernesto Pontieri, Nicolas Vuillerme

    Published in JMIR Formative Research (2025-03-01)
    Get full text
    Article


  9. 9

    Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson’s disease by Luisa Di Menna, Marika Alborghetti, Maria Ilenia De Bartolo, Marina Borro, Giovanna Gentile, Manuela Zinni, Matteo Bologna, Carolina Cutrona, Giovanna D’Errico, Tiziana Imbriglio, Domenico Bucci, Sara Merlo, Roxana Paula Ginerete, Rosamaria Orlando, Federica Carrillo, Giorgio Fortunato, Milena Cannella, Maria Angela Sortino, Julien Pansiot, Olivier Baud, Ferdinando Nicoletti, Valeria Bruno, Maurizio Simmaco, Francesco Ernesto Pontieri, Edoardo Bianchini, Domiziana Rinaldi, Amalia de Curtis, Giovanni De Gaetano, Licia Iacoviello, Teresa Esposito, Alfredo Berardelli, Giuseppe Battaglia

    Published in npj Parkinson's Disease (2025-01-01)
    Get full text
    Article


Search Tools: